Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Pfizer Is Best Positioned Big Pharma in China - Goldman
- ChinaBio Today submits: In an investment review of Pfizer (NYSE: PFE), Goldman Sachs said sales in emerging growth markets would become a significant factor in the company’s revenues, a fact that it considers underappreciated by stock market investors. China is the major emerging market for Pfizer. Goldman expects...
- External links 2009-11-20
- Sinovac Testing Swine Flu Vaccine
- ChinaBio Today submits: Six weeks after receiving their first samples of the A/H1N1 swine flu virus, two China biotechs have begun clinical trials of vaccines for the potentially fatal version of flu. Sinovac Biotech Ltd. SVA and Hualan Biological Engineering will each test their vaccines in about 2,000 volunteers,...
- External links 2009-07-23
- American Oriental Makes China's Top 20 Pharmas List, Aims for Top Five
- ChinaBio Today submits: American Oriental Bioengineering, Inc. (NYSE: AOB) was selected as one of the "Top 20 Most Competitive Public Pharmaceutical Companies in China." The honor came after American Oriental was chosen from 132 China public pharmaceutical companies whose shares are traded on exchanges in China, the US or...
- External links 2009-07-22
- Mindray Medical Releases Product Update
- ChinaBio Today submits: Mindray Medical International Limited (NYSE: MR) issued an update of its additions to its line of medical products last week, announcing it has introduced five new products so far in 2009. Four of them are additions to its patient monitoring and life support business, while the...
- External links 2009-07-21
- Biostar Pharma Wins Approval for Three New TCM Products
- ChinaBio Today submits: Biostar Pharmaceuticals, Inc. (BSPM.OB) received local approval for three TCM products, which it expects to begin selling later this month. The company projects a total of $3.5 million in revenues from the three products in 2009, and $7.4 million in 2010. Biostar anticipates they will produce...
- External links 2009-07-17
- China Medicine Reports Positive Data on Animal Feed Additive
- ChinaBio Today submits: China Medicine Corporation (CHME.OB) reported positive results from a third party feasibility report on a product in development, recombinant Aflatoxin Detoxifizyme rADTZ, a food and feed additive directed at detoxifying aflatoxin (AFT). rADTZ is a potential cancer causing agent. The report was produced by the Feed...
- External links 2009-07-17
- China-Biotics Reports Gains in FY2009
- ChinaBio Today submits: China-Biotics, Inc. (NSDQ: CHBT) reported positive financial results for its 2009 fiscal year, which ended in March. Sales rose 28% to $54.2 million, and non-GAAP net income climbed 19% to $16.9 million, a very healthy margin of 31%. Revenues were in line with analysts’ expectations, but...
- External links 2009-07-15
- China Sky One Wins Good Manufacturing Practices Renewal
- ChinaBio Today submits: China Sky One Medical (NSDQ: CSKI) reported that its new Peng Lai Jin Chuang Pharmaceutical Company subsidiary received an SFDA renewal of its Good Manufacturing Practices Certificate. The certificate is good for five years.China Sky One closed its purchase of Jin Chuang in September 2008. For...
- External links 2009-07-15
- Neuralstem Sponsors Stem Cell Research in Taiwan
- ChinaBio Today submits: Neuralstem CUR will sponsor stem cell research at the China Medical University & Hospital of Taiwan. The work will help prepare for a human clinical trial using Neuralstem’s human spinal cord neural stem cells to treat patients who have suffered a stroke. The patient population will...
- External links 2009-07-14
- Chemspec IPO Opens Strong
- ChinaBio Today submits: During the past week, two China pharma-related companies successfully completed their IPOs, ending a long drought of new offerings. Guilin Sanjin Pharmaceutical Co, a traditional Chinese medicine company, will make its debut on the Shenzhen exchange. On the New York Stock Exchange, chemical company Chemspec CPC,...
- External links 2009-07-05
- Bayer Launches New Anti-Clotting Drug in China
- ChinaBio Today submits: Bayer Healthcare (BAYRY.PK) has launched its new anti-clotting drug Xarelto rivaroxaban in China following SFDA approval. As Liam Condon, Managing Director of Bayer HealthCare China said at last week’s ChinaBio® Partnering Forum, the fact that Xarelto was approved in China before the US shows Bayer’s commitment...
- External links 2009-07-05
- NeoStem Raises an Additional $4 Million
- ChinaBio Today submits: NeoStem, Inc. NBS has raised another $4 million from institutional and private investors. The terms of the funding were the same as those for the company’s previous fund raising, an $11 million private placement in April involving three Asia-based investors. Also, affiliates of Suzhou...
- External links 2009-07-05
- WuXi: One of China's Top 10 Outsourcing Companies
- ChinaBio Today submits: WuXi PharmaTech WX was named one of the Top Ten Leading Outsourcing Enterprises in China, a list selected by China’s Ministry of Commerce. The ministry announced the composition of the list at the Second Annual China International Service Outsourcing Cooperation Conference, held in Nanjing on June...
- External links 2009-07-05
- China Pharma Wins OK for Generic Cholesterol Drug Trials
- ChinaBio Today submits: China Pharma Holdings (CPHI.OB) obtained approval from the SFDA to begin Phase I and Phase II clinical trials of Rosuvastatin, a generic version of the cholesterol-lowering statin drug Crestor. The trials will test the compound for efficacy. China Pharma will move to begin the trials immediately...
- External links 2009-06-23
- Sinovac Gets Significant Order for H1N1 Flu Vaccine
- ChinaBio Today submits: Sinovac Biotech (NYSE Amex: SVA) received the first order for its influenza A (H1N1) vaccine from the Beijing government. The initial order, consisting of 4 million doses, will be administered to 2 million high risk people. Following delivery of the first order at the end of...
- External links 2009-06-22
- Sinovac Claims Bragging Rights as First Vaccine Maker to Complete Swine Flu Test
- ChinaBio Today submits: Sinovac Biotech Ltd. SVA reported that its swine flu (H1N1) vaccine was effective after a single dose. The seropositive rate, seroconvertive rate and GMT increasing multiple have reached the international criteria for vaccines, which indicates that Sinovac's H1N1 vaccine has good immunogenicity and offers protection. The...
- External links 2009-08-18
- GSK to Distribute Dr. Reddy's Generics in Emerging Markets
- ChinaBio Today submits: GlaxoSmithKline (NYSE: GSK) has partnered up with Dr. Reddy's Laboratories (NYSE: RDY) in a deal that will allow GSK to sell Dr. Reddy’s generic pharmaceutical products in emerging markets. The targeted countries include China, though Dr. Reddy’s home market of India is excluded. GSK has the...
- External links 2009-07-23
- J&J Wins Approval to Market MDS Drug Without China Trials
- ChinaBio Today submits: Xian-Janssen, a division of Johnson & Johnson (NYSE: JNJ) has launched a new drug in China. Dacogen decitabine, a novel treatment for myelodysplastic syndrome, received SFDA approval through the Green Channel, an expedited approval process that the SFDA introduced in January 2009. In Dacogen’s case, the...
- External links 2009-07-25
- China Sky One Reports Record Results for Q2
- ChinaBio Today submits: China Sky One Medical (NSDQ: CSKI) reported record high results for Q2 of 2009, and the company reiterated its guidance for full-year 2009. During the second quarter, revenue climbed 36% to $32.2 million, while net income rose 17% to $9.5 million, or 57 cents per share,...
- External links 2009-08-18
- Tinayin Pharma Adds Two New Products to TCM Portfolio
- ChinaBio Today submits: Tianyin Pharmaceutical Co., Inc. TPI received SFDA approvals for two new products: 0.5 gram/tablet formulations of Sanqi Tablets and Yinqiao Jiedu Tablets. Sanqi is a generic TCM that treats traumatic injuries and stops bleeding without causing blood stasis, while alleviating pain and reducing swelling. Also a...
- External links 2009-08-16
- << Previous
- page 1 of 13
- Next >>
Refining Tags
- China (229 results)
- Biotech (39 results)
- Seeking Alpha (34 results)
- China Sky One Medical Inc. (24 results)
- Finance (23 results)
- Sinovac Biotech Ltd. (21 results)
- Healthcare (16 results)
- Operational Accounting (11 results)
- American Oriental Bioengineering Inc. (10 results)
- Revenue (10 results)
- Financial Accounting (9 results)
- Beijing Med-Pharm Corp. (9 results)
- Pfizer Inc. (9 results)
- Investment (9 results)
- Mergers & Acquisitions (7 results)
- NeoStem Inc. (7 results)
- Pharmaceutical Company (7 results)
- Net Income (6 results)
- Business Operations (6 results)
- GAAP (5 results)
- Eli Lilly & Co. (5 results)
- Corporate Law (5 results)
- Charles River Laboratories International Inc. (4 results)
- Drug (4 results)
- China-Biotics Inc. (4 results)
- Acquisition (4 results)
- Novartis AG (3 results)
- Sales Strategy (3 results)
- Sales (3 results)
- GlaxoSmithKline Plc. (3 results)
- Johnson & Johnson (3 results)
- Manufacturing (3 results)
- Investor (3 results)
